InfuSystems Holdings Inc (INFU)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX
Market Cap: $294.89M
Last updated: Nov 17, 2026 at 11:05 AM ET
InfuSystems Holdings Inc (INFU) Stock Forecast
Analysts expect InfuSystems Holdings (INFU) to earn $0.49 per share in the fiscal year ending Dec 31, 2026, on revenue of $145.47M. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $0.56.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 3 | 100.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 14.3% and revenue estimates rise 5.9%.
- Fiscal year ending Dec 31, 2026
- $0.49
- EPS consensus, revenue $145.47M
- Fiscal year ending Dec 31, 2027
- $0.56
- EPS consensus, revenue $154.04M
- Next report
- Feb 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.49 | $0.49 to $0.49 | 1 | $145.47M | $145.21M to $145.62M | 3 |
| Dec 31, 2027 | $0.56 | $0.56 to $0.56 | 1 | $154.04M | $152.30M to $155.31M | 3 |
Quarterly Estimates
The EPS consensus falls from $0.16 for the quarter ending Dec 31, 2026 to $0.07 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.16 | $0.13 to $0.18 | 5 | $39.04M | $36.65M to $42.00M | 5 |
| Mar 31, 2027 | $0.07 | $0.07 to $0.07 | 1 | $35.34M | $34.51M to $36.50M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 30 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 6.5% from $0.46.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.49 | $0.46 | $0.46 | N/A | N/A | N/A |
| Fiscal year ending Dec 31, 2027 | $0.56 | $0.52 | $0.52 | N/A | N/A | N/A |
| Quarter ending Mar 31, 2027 | $0.07 | $0.05 | $0.05 | N/A | N/A | N/A |
Frequently Asked Questions About INFU
What is the INFU stock forecast?
Consensus analyst estimates put InfuSystems Holdings's EPS at $0.49 for the fiscal year ending Dec 31, 2026, on revenue of $145.47M. The consensus rating from 3 analysts is Buy.
How do analysts rate INFU stock?
Of 3 analysts covering InfuSystems Holdings, 0 rate it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from INFU next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.49, with estimates from $0.49 to $0.49 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.56, with estimates from $0.56 to $0.56 from 1 analyst.
What revenue do analysts expect from InfuSystems Holdings next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $145.47M, with estimates from $145.21M to $145.62M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $154.04M, with estimates from $152.30M to $155.31M.
How many analysts cover INFU?
3 analysts rate InfuSystems Holdings stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
INFU pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors